Carbamazepine (CBZ) Industry Forecast 2017-2022 Global Carbamazepine (CBZ) Market Outlook 2017-202 Clique para ler
  • Comentários

Carbamazepine (CBZ) Industry Forecast 2017-2022

Global Carbamazepine (CBZ) Market Outlook 2017-202

Publicado no e em "Negócios", idioma — English. 5 páginas.
This report provides detailed analysis of worldwide markets for Carbamazepine (CBZ) from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the volumes, prices, historical growth and future perspectives in the Carbamazepine (CBZ) market and further lays out an analysis of the factors influencing the supply/demand for Carbamazepine (CBZ), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to co Mais
Carbamazepine (CBZ), sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. For seizures it works as well as phenytoin and valproate. It is not effective for absence seizures or myoclonic seizures. It may be used in schizophrenia along with other medications and as a second line agent in bipolar disorder. Mais
Mostrar Tags
Assine GRÁTIS